Browsing by Subject "Factor VIIa"
Now showing items 1-1 of 1
-
(2011)Background and Purpose: Dabigatran-etexilate (DE) recently has been approved for stroke prevention in atrial fibrillation. However, lack of effective antagonists represents a major concern in the event of intracerebral ...